Roche’s Evrysdi Approved in Singapore for Treatment of Spinal Muscular Atrophy (SMA)
The oral medication is available for adults and children two months and older. Roche announced in June 2022 that the Health Sciences Authority (HSA) in Singapore has approved Evrysdi™ (risdiplam)...